The Liege Acromegaly Survey (LAS) : A new software tool for the study of acromegaly

PETROSSIANS, Patrick; Tichomirowa, M; Stevenaert, Achille; MARTIN, Didier; Daly, Adrian; Beckers, Albert

doi:10.1016/j.ando.2012.05.001

Request a copy

Article (Scientific journals)

The Liege Acromegaly Survey (LAS) : A new software tool for the study of acromegaly

PETROSSIANS, Patrick; Tichomirowa, M; Stevenaert, Achille et al.

2012 • In Annales d'Endocrinologie, 73, p. 190-201

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/127145

DOI
10.1016/j.ando.2012.05.001

PubMed
22682917

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

AnnalesEndo-Pétro2012.pdf

Publisher postprint (733.44 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

PETROSSIANS, Patrick ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique

Tichomirowa, M

Stevenaert, Achille ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)

MARTIN, Didier ; Centre Hospitalier Universitaire de Liège - CHU > Neurochirurgie

Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie

Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie

Language :

English

Title :

The Liege Acromegaly Survey (LAS) : A new software tool for the study of acromegaly

Publication date :

2012

Journal title :

Annales d'Endocrinologie

ISSN :

0003-4266

eISSN :

2213-3941

Publisher :

Masson, Moulineaux Cedex 9, France

Volume :

Pages :

190-201

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 11 July 2012

Statistics

Number of views

133 (14 by ULiège)

Number of downloads

8 (6 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Chanson P., Salenave S. Acromegaly. Orphanet J Rare Dis 2008, 3:17. [Epub 2008/06/27. http://dx.doi.org/10.1186/1750-1172-3-17. PubMed PMID: 18578866; PubMed Central PMCID: PMC2459162].
Vasilev V., Daly A., Zacharieva S., Beckers A. Management of acromegaly. F1000 Med Rep 2010, 2:54. [Epub 2010/12/22. http://dx.doi.org/10.3410/M2-54. PubMed PMID: 21173856; PubMed Central PMCID: PMC2990454].
Chanson P., Bertherat J., Beckers A., Bihan H., Brue T., Caron P., et al. French consensus on the management of acromegaly. Ann Endocrinol 2009, 70(2):92-106. [Epub 2009/04/07. http://dx.doi.org/10.1016/j.ando.2008.12.011. PubMed PMID: 19345931].
Daly A.F., Tichomirowa M.A., Beckers A. The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 2009, 23(5):543-554. [Epub 2009/12/01. http://dx.doi.org/10.1016/j.beem.2009.05.008. PubMed PMID: 19945022].
Stewart P.M. Acromegaly databases - time for European unification. Eur J Endocrinol 2004, 151(4):431-432. [Epub 2004/10/13. PubMed PMID: 15476440].
Drange M.R., Fram N.R., Herman-Bonert V., Melmed S. Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab 2000, 85(1):168-174. [Epub 2000/01/14. PubMed PMID: 10634382].
Fieffe S., Morange I., Petrossians P., Chanson P., Rohmer V., Cortet C., et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol 2011, 164(6):877-884. [Epub 2011/04/06. http://dx.doi.org/10.1530/EJE-10-1050. PubMed PMID: 21464140].
Jaquet P., Cortet-Rudelli C., Sassolas G., Morange-Ramos I., Chanson P., Brue T., et al. Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry. Ann Endocrinol 2003, 64(6):434-441. [Epub 2004/04/07. PubMed PMID: 15067248].
Dupuy O., Petrossians P., Brue T., Morange I., Bordier L., Mayaudon H., et al. Acromegaly in the elderly. Ann Endocrinol. 2009, 70(4):225-229. [Epub 2009/06/23. http://dx.doi.org/10.1016/j.ando.2009.05.002. PubMed PMID: 19539897].
Trainer P.J. ACROSTUDY: the first 5 years. Euro J Endocrinol 2009, 161(Suppl. 1):S19-S24. [Epub 2009/08/18. http://dx.doi.org/10.1530/EJE-09-0322. PubMed PMID: 19684052].
Luger A., Feldt-Rasmussen U., Abs R., Gaillard R.C., Buchfelder M., Trainer P., et al. Lessons learned from 15 years of KIMS and 5 years of ACROSTUDY. Horm Res Paediatr. 2011, 76(Suppl. 1):33-38. [Epub 2011/08/04. http://dx.doi.org/10.1159/000329156. PubMed PMID: 21778746].
van der Lely A.J., Biller B.M., Brue T., Buchfelder M., Ghigo E., Gomez R., et al. Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab 2012, [Epub 2012/03/01. http://dx.doi.org/10.1210/jc.2011-2508. PubMed PMID: 22362824].
Bex M., Abs R., T'Sjoen G., Mockel J., Velkeniers B., Muermans K., et al. AcroBel - the Belgian registry on acromegaly: a survey of the "real-life" outcome in 418 acromegalic subjects. Eur J Endocrinol 2007, 157(4):399-409. [Epub 2007/09/26. http://dx.doi.org/10.1530/EJE-07-0358. PubMed PMID: 17893253].
Reincke M., Petersenn S., Buchfelder M., Gerbert B., Skrobek-Engel G., Franz H., et al. The German Acromegaly Registry: description of the database and initial results. Exp Clin Endocrinol Diabetes 2006, 114(9):498-505. [Epub 2006/11/23. http://dx.doi.org/10.1055/s-2006-948313. PubMed PMID: 17115347].
Petersenn S., Buchfelder M., Gerbert B., Franz H., Quabbe H.J., Schulte H.M., et al. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clin Endocrinol 2009, 71(3):400-405. [Epub 2009/02/20. http://dx.doi.org/10.1111/j.1365-2265.2009.03547.x. PubMed PMID: 19226273].
Mestron A., Webb S.M., Astorga R., Benito P., Catala M., Gaztambide S., et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004, 151(4):439-446. [Epub 2004/10/13. PubMed PMID: 15476442].
Sesmilo G., Gaztambide S., Venegas E., Pico A., Del Pozo C., Blanco C., et al. Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary 2012, [Epub 2012/04/07. http://dx.doi.org/10.1007/s11102-012-0384-x. PubMed PMID: 22481632].
Team R.D.C. R: a language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
Sarkar D. Lattice: multivariate data visualization with R. New York: 2008.
Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28(7):412-419. [Epub 1985/07/01. PubMed PMID: 3899825].
Fukuoka H., Takahashi Y., Iida K., Kudo T., Nishizawa H., Imanaka M., et al. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly. Horm Res. 2008, 69(3):165-171. [Epub 2008/01/26. http://dx.doi.org/10.1159/000112590. PubMed PMID: 18219220].
Stevenaert A., Beckers A. Presurgical octreotide treatment in acromegaly. Acta Endocrinol. 1993, 129(Suppl. 1):18-20. [Epub 1993/07/01. PubMed PMID: 8372606].
van der Lely A.J., Harris A.G., Lamberts S.W. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin Endocrinol 1992, 37(2):181-185. [Epub 1992/08/01. PubMed PMID: 1395069].
Nabarro J.D. Acromegaly. Clin Endocrinol 1987, 26(4):481-512. [Epub 1987/04/01. PubMed PMID: 3308190].
Nachtigall L., Delgado A., Swearingen B., Lee H., Zerikly R., Klibanski A. Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 2008, 93(6):2035-2041. [Epub 2008/04/03. http://dx.doi.org/10.1210/jc.2007-2149. PubMed PMID: 18381584].
Alexander L., Appleton D., Hall R., Ross W.M., Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980, 12(1):71-79. [Epub 1980/01/01. PubMed PMID: 7379316].
Daly A.F., Jaffrain-Rea M.L., Ciccarelli A., Valdes-Socin H., Rohmer V., Tamburrano G., et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 2006, 91(9):3316-3323. [Epub 2006/06/22. http://dx.doi.org/10.1210/jc.2005-2671. PubMed PMID: 16787992].
Daly A.F., Vanbellinghen J.F., Khoo S.K., Jaffrain-Rea M.L., Naves L.A., Guitelman M.A., et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007, 92(5):1891-1896. [Epub 2007/01/25. http://dx.doi.org/10.1210/jc.2006-2513. PubMed PMID: 17244780].
Daly A.F., Tichomirowa M.A., Petrossians P., Heliovaara E., Jaffrain-Rea M.L., Barlier A., et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 2010, 95(11):E373-E383. [Epub 2010/08/06. http://dx.doi.org/10.1210/jc.2009-2556. PubMed PMID: 20685857].
Cazabat L., Bouligand J., Salenave S., Bernier M., Gaillard S., Parker F., et al. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab 2012, [Epub 2012/02/10. http://dx.doi.org/10.1210/jc.2011-2291. PubMed PMID: 22319033].
Petrossians P., Borges-Martins L., Espinoza C., Daly A., Betea D., Valdes-Socin H., et al. Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur J Endocrinol 2005, 152(1):61-66. [Epub 2005/03/15. PubMed PMID: 15762188].